Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Krebs cycle enzyme fumarate hydratase (FH) is a human tumor suppressor whose inactivation is associated with the development of leiomyomata, renal cysts, and tumors. It has been proposed that activation of hypoxia inducible factor (HIF) by fumarate-mediated inhibition of HIF prolyl hydroxylases drives oncogenesis. Using a mouse model, we provide genetic evidence that Fh1-associated cyst formation is Hif independent, as is striking upregulation of antioxidant signaling pathways revealed by gene expression profiling. Mechanistic analysis revealed that fumarate modifies cysteine residues within the Kelch-like ECH-associated protein 1 (KEAP1), abrogating its ability to repress the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-mediated antioxidant response pathway, suggesting a role for Nrf2 dysregulation in FH-associated cysts and tumors.

Original publication




Journal article


Cancer Cell

Publication Date





524 - 537


Adaptor Proteins, Signal Transducing, Animals, Antioxidants, Cell Hypoxia, Cytoskeletal Proteins, Fumarate Hydratase, Fumarates, Gene Expression Regulation, Neoplastic, Hypoxia-Inducible Factor 1, Kelch-Like ECH-Associated Protein 1, Kidney Diseases, Cystic, Mice, NF-E2-Related Factor 2, Procollagen-Proline Dioxygenase, Signal Transduction, Succinates